Eliglustat compared with imiglucerase in patients with Gaucher's disease type 1 stabilised on enzyme replacement therapy: a phase 3, randomised, open-label, non-inferiority trial. (2015)

First Author: Cox TM
Attributed to:  Gene Therapy for Tay-Sachs and Sandhoff diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(14)61841-9

PubMed Identifier: 25819691

Publication URI: http://europepmc.org/abstract/MED/25819691

Type: Journal Article/Review

Volume: 385

Parent Publication: Lancet (London, England)

Issue: 9985

ISSN: 0140-6736